StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) operating KPIs

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)

Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%

Cvs Health peer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues ($M)

Annual figures from Cvs Health's filings and investor materials

Latest, FY2025
199,125
Period ended Dec 31, 2025
Change on a year earlier
+12.5%
177,011 in FY2024
History
10 years
Since FY2016
Sources
2
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPeer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues ($M)Year on yearSource
FY2025Dec 31, 2025199,125+12.5%Elevance Health, Inc. SEC 10-K (XBRL) ↗
FY2024Dec 31, 2024177,011+3.3%Elevance Health, Inc. SEC 10-K (XBRL) ↗
FY2023Dec 31, 2023171,340+9.4%Elevance Health, Inc. SEC 10-K (XBRL) ↗
FY2022Dec 31, 2022156,595+13.0%Elevance Health, Inc. SEC 10-K (XBRL) ↗
FY2021Dec 31, 2021138,639+13.8%Elevance Health, Inc. SEC 10-K (XBRL) ↗
FY2020Dec 31, 2020121,867+16.9%Elevance Health, Inc. SEC 10-Q (XBRL) ↗
FY2019Dec 31, 2019104,213+13.1%Elevance Health, Inc. SEC 10-K (XBRL) ↗
FY2018Dec 31, 201892,105+2.3%Elevance Health, Inc. SEC 10-K (XBRL) ↗
FY2017Dec 31, 201790,040+6.1%Elevance Health, Inc. SEC 10-K (XBRL) ↗
FY2016Dec 31, 201684,863–Elevance Health, Inc. SEC 10-K (XBRL) ↗

Breakdown

What makes up peer benchmark — elevance health (elv / carelon, through q3 2026): total revenues

Cite this data

StockData. (2026). Cvs Health Peer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues ($M), annual FY2016–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer_elv_revenue

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.